# Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women

> **NCT01181323** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 240 (actual)

## Conditions studied

- Influenza

## Interventions

- **OTHER:** Placebo
- **BIOLOGICAL:** Cold-adapted live attenuated influenza virus vaccine, trivalent
- **OTHER:** Placebo
- **BIOLOGICAL:** Trivalent inactivated influenza vaccine

## Key facts

- **NCT ID:** NCT01181323
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2015-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181323, "Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01181323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*